India joins global drug discovery league The launch by Ranbaxy last week of Synriam, a new drug to treat malaria, is an important milestone. Having made its name by manufacturing generic (off patent) drugs cheaply, India’s pharmaceutical industry has struggled to achieve original drug discovery since the Uruguay Round of trade negotiations signalled the onset of product patents in India. It began to be realised, in time, that there was...

The economic crisis, the ecological crisis and the food crisis are a reflection of an outmoded and fossilised economic paradigm. It is a paradigm that grew out of mobilising resources for the war by creating the category of “growth”. It is rooted in the age of oil and fossil fuels. It is fossilised because it is obsolete, a product of the age of fossil fuels. If we have to address...

Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...

A fourth of school students will need to be from less-privileged sections of society following an SC ruling on the RTE Act. While this can bring in social transformation, there are implementation challenges. Educationists share some solutions with Labonita Ghosh  Problem 1: WHO WILL FOOT THE BILL?  The government has offered to pay for the 25% of less-privileged students who will now have to be admitted into private schools, but it's not...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...